Oxervate Lawsuit: Know the Risks of Using Eye Drops

1. Oxervate Lawsuit: Know the Risks of Using Eye Drops Oxervate, an FDA-approved eye drop for neurotrophic keratitis, is linked to severe side effects like blindness. Patients are seeking legal compensation, alleging inadequate warnings from the manufacturer, Dompé. Learn more about the Oxervate lawsuits in the article. Oxervate is a prescription eye drop created by an Italian company named Dompé farmaceutici S.p.A. It was approved by the U.S. Food and Drug Administration (FDA) in 2018. Oxervate is designed to treat a rare eye disease called neurotrophic keratitis. This condition affects the cornea, the clear front part of the eye, causing it to lose sensation due to nerve damage. When the cornea can't sense pain, it doesn't heal properly, leading to ulcers and potentially blindness. Oxervate contains a substance called cenegermin, which is a nerve growth factor. This means it helps the nerves in the cornea to grow and heal. By applying these eye drops, patients can regenerate the damaged nerves, improve sensation in the cornea, and promote healing. https://www.medlegal360.com/

2. One of the key studies supporting Oxervate's approval was the REPARO trial. This study involved 156 patients who were treated either with cenegermin eye drops or a placebo (a treatment with no active drug) for eight weeks. The results were promising: 72% of patients using Oxervate showed complete corneal healing compared to only 33% in the placebo group. Based on these results, the FDA approved Oxervate for treating neurotrophic keratitis. Despite its early success, Oxervate has been linked to serious side effects. Some patients have reported severe eye problems, including: Blindness Blurred vision Corneal ulcers Corneal perforation Severe eye inflammation Recent data from the FDA's adverse event reporting system revealed 3,288 cases of eye-related issues linked to cenegermin. This includes 50 unexpected and 20 serious events like corneal perforation and eye infections. Due to these severe side effects, some patients and lawyers are considering legal action against Dompé. They claim that the company did not adequately warn patients about the risks associated with Oxervate. If it can be proven that Dompé knew about these risks and did not disclose them, affected patients might be entitled to compensation for their pain, suffering, and medical expenses. If you have suffered from the adverse effects of Oxervate, it is important to know your legal rights. Filing an Oxervate lawsuit can help you seek compensation and hold the manufacturer accountable for not providing adequate warnings. Legal experts can help assess your case, guide you through the process, and ensure your health and rights are protected. Oxervate offers hope for people with neurotrophic keratitis, but it also comes with significant risks. If you have experienced these adverse effects, understanding your legal rights and seeking compensation can help protect your health and ensure you get the support you need. Contact a specialized attorney to explore your legal options. https://www.medlegal360.com/